Macquarie Group LTD Myriad Genetics Inc Transaction History

Macquarie Group LTD

  • $86.4 Billion
  • Q4 2024

A detailed history of Macquarie Group LTD transactions in Myriad Genetics Inc stock. As of the latest transaction made, Macquarie Group LTD holds 155,947 shares of MYGN stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,947
Previous 147,593 5.66%
Holding current value
$1.56 Million
Previous $4.04 Million 47.07%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$13.17 - $27.03 $110,022 - $225,808
8,354 Added 5.66%
155,947 $2.14 Million
Q3 2024

Nov 14, 2024
BUY
$23.97 - $28.6 $15,987 - $19,076
667 Added 0.45%
147,593 $4.04 Million
Q2 2024

Aug 09, 2024
SELL
$17.98 - $25.47 $2,013 - $2,852
-112 Reduced 0.08%
146,926 $3.59 Million
Q1 2024

May 14, 2024
SELL
$17.59 - $23.59 $29,762 - $39,914
-1,692 Reduced 1.14%
147,038 $3.13 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $439,528 - $673,669
31,598 Added 26.98%
148,730 $2.85 Million
Q3 2023

Nov 14, 2023
BUY
$15.99 - $23.22 $20,930 - $30,394
1,309 Added 1.13%
117,132 $1.88 Million
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $336,748 - $455,645
-19,177 Reduced 14.21%
115,823 $2.68 Million
Q4 2022

Feb 21, 2023
SELL
$14.51 - $20.99 $11,375 - $16,456
-784 Reduced 0.58%
135,000 $1.96 Million
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $15,223 - $23,307
-836 Reduced 0.61%
135,784 $2.61 Million
Q2 2021

Aug 13, 2021
SELL
$25.39 - $32.61 $35,622 - $45,751
-1,403 Reduced 1.02%
136,620 $4.18 Million
Q1 2021

May 14, 2021
SELL
$19.92 - $31.6 $21,135 - $33,527
-1,061 Reduced 0.76%
138,023 $4.2 Million
Q2 2020

Aug 11, 2020
BUY
$10.69 - $16.49 $8,380 - $12,928
784 Added 0.57%
139,084 $1.58 Million
Q4 2019

Feb 14, 2020
SELL
$20.93 - $35.1 $71,162 - $119,340
-3,400 Reduced 2.4%
138,300 $3.77 Million
Q3 2019

Nov 14, 2019
SELL
$22.08 - $47.08 $117,023 - $249,524
-5,300 Reduced 3.61%
141,700 $4.06 Million
Q2 2019

Aug 14, 2019
BUY
$22.67 - $35.0 $272,040 - $420,000
12,000 Added 8.89%
147,000 $4.08 Million
Q4 2018

Feb 15, 2019
SELL
$27.23 - $45.56 $5,446 - $9,112
-200 Reduced 0.15%
135,000 $3.92 Million
Q3 2018

Nov 15, 2018
SELL
$37.57 - $50.34 $146,523 - $196,326
-3,900 Reduced 2.8%
135,200 $6.22 Million
Q2 2018

Aug 14, 2018
SELL
$27.75 - $40.17 $194,250 - $281,190
-7,000 Reduced 4.79%
139,100 $5.2 Million
Q1 2018

May 11, 2018
BUY
$28.83 - $41.01 $17,298 - $24,606
600 Added 0.41%
146,100 $4.32 Million
Q4 2017

Feb 15, 2018
BUY
$28.45 - $37.14 $298,725 - $389,970
10,500 Added 7.78%
145,500 $5 Million
Q3 2017

Nov 08, 2017
BUY
$24.01 - $36.2 $3.24 Million - $4.89 Million
135,000
135,000 $4.88 Million

Others Institutions Holding MYGN

# of Institutions
228
Shares Held
92M
Call Options Held
297K
Put Options Held
20.7K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $807M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email